Viavi (VIAV) Files Form 144 for 11,873-Share Sale on NASDAQ

Rhea-AI Filing Summary

Viavi Solutions Inc. (VIAV) submitted a Form 144 notice for a planned sale of 11,873 common shares valued at $132,693.84, to be executed approximately on 08/29/2025 on the NASDAQ. The shares represent a small portion of the company's common stock, with 223,245,915 shares outstanding, and were acquired as restricted stock from the issuer on 08/28/2025. The filing reports no sales by the seller in the past three months and indicates the transaction will be brokered by Morgan Stanley Smith Barney LLC. The filer attests they are not aware of undisclosed material adverse information and notes the usual Rule 10b5-1/attestation language on trading plans and criminal penalties for misstatements.

Positive

• Disclosure compliance: Filing provides required Rule 144 information including broker, number of shares, market value, and acquisition details
• Immaterial size: 11,873 shares (~$132,694) is a negligible fraction of 223,245,915 shares outstanding, implying limited market impact

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine insider sale of recently issued restricted stock; negligible dilution and limited investor impact.

The notice documents a proposed sale of 11,873 shares (~$132.7k) against 223.25 million shares outstanding, representing roughly 0.0053% of the outstanding stock, so the transaction is immaterial to market capitalization or control. The shares were acquired as restricted stock from the issuer one day prior to the planned sale, suggesting a planned post-vesting disposition rather than open-market accumulation. No prior sales in the past three months were reported, and the trade is to be executed through a major broker on NASDAQ. From an investor perspective this filing is a routine disclosure required by Rule 144; it does not indicate company-level financial stress or material corporate events.

Corporate Governance Expert

TL;DR: Compliance-focused filing; attestation and broker involvement align with standard governance and insider-sale procedures.

The Form 144 includes the standard attestation that the seller lacks undisclosed material adverse information and references Rule 10b5-1 considerations. The use of Morgan Stanley Smith Barney as broker and the immediate timing after acquisition imply adherence to procedures for disposing of restricted shares. There is no indication of accelerated insider selling or systemic governance concerns based on the disclosed quantity and absence of recent prior sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11873	132693.84	223245915	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2025	Restricted Stock	ISSUER			11873	08/28/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Viavi's Form 144 for symbol VIAV disclose?

The Form 144 discloses a proposed sale of 11,873 common shares valued at $132,693.84, to be sold around 08/29/2025 on the NASDAQ through Morgan Stanley Smith Barney LLC.

When were the shares being sold acquired according to the Form 144?

The shares were acquired as restricted stock from the issuer on 08/28/2025 and payment was recorded the same day.

How material is this proposed sale relative to Viavi's outstanding shares?

The proposed sale represents about 0.0053% of the 223,245,915 shares outstanding, indicating the sale is immaterial to overall share count.

Did the filer report any securities sold in the past three months?

No. The Form 144 indicates Nothing to Report for securities sold during the past three months by the seller.

Which broker is handling the proposed sale listed in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.